Aandeel IMUC EOM PHARMACEUTICALS HOLDINGS, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen EOM Pharmaceuticals Holdings, Inc.

Aandelen

IMUC

US4525364026

Beurs gesloten - OTC Markets
Andere beurzen
 15:40:05 10-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,21 USD +40,00% Intraday-grafiek van EOM Pharmaceuticals Holdings, Inc. +14,13% -9,48%
2023 EOM Pharmaceutical Holdings kondigt topline resultaten aan van zijn Covid-19 klinische studie van Eom613 in Brazilië CI
2023 EOM Pharmaceuticals Holdings, Inc. heeft zijn IPO voor een bedrag van $15 miljoen ingetrokken. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
EOM Pharmaceutical Holdings Announces Topline Results of Its Covid-19 Clinical Trial of Eom613 in Brazil
EOM Pharmaceuticals Holdings, Inc. has withdrawn its IPO in the amount of $15 million.
EOM Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ImmunoCellular Therapeutics Ltd. has Changed its Name to EOM Pharmaceuticals Holdings, Inc
EOM Pharmaceuticals Holdings, Inc. announced that it has received $0.75 million in funding
EOM Pharmaceuticals Holdings, Inc. announced a financing transaction
EOM Pharmaceuticals Holdings, Inc. has filed an IPO in the amount of $25 million.
ImmunoCellular Therapeutics, Ltd. Auditor Raises 'Going Concern' Doubt
ImmunoCellular Therapeutics, Ltd. Auditor Raises 'Going Concern' Doubt
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
EOM Pharmaceuticals, Inc. acquired ImmunoCellular Therapeutics, Ltd. in a reverse merger transaction.
ImmunoCellular Therapeutics : Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market
ImmunoCellular Therapeutics, Ltd.(AMEX:IMUC) dropped from S&P TMI Index
ImmunoCellular Therapeutics, Ltd. Announces Executive Changes, Effective October 15, 2018
ImmunoCellular Therapeutics, Ltd. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018
ImmunoCellular Therapeutics Is Considering Strategic Alternatives
ImmunoCellular Therapeutics, Ltd. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
ImmunoCellular Therapeutics, Ltd. Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers IMUC
  4. Nieuws EOM Pharmaceuticals Holdings, Inc.
  5. Andere talen